{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T15:57:31Z","timestamp":1791388651484,"version":"4.3.3"},"reference-count":51,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,21]],"date-time":"2022-07-21T00:00:00Z","timestamp":1658361600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002338","name":"Ministry of Education of the People's Republic of China","doi-asserted-by":"publisher","award":["2172019kfyRCPY069"],"award-info":[{"award-number":["2172019kfyRCPY069"]}],"id":[{"id":"10.13039\/501100002338","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019230","name":"Wuhan Union Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019230","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82073178"],"award-info":[{"award-number":["82073178"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82073321"],"award-info":[{"award-number":["82073321"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82102789"],"award-info":[{"award-number":["82102789"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.celrep.2022.111194","type":"journal-article","created":{"date-parts":[[2022,8,16]],"date-time":"2022-08-16T10:43:03Z","timestamp":1660646583000},"page":"111194","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":139,"title":["S-palmitoylation of PCSK9 induces sorafenib resistance in liver cancer by activating the PI3K\/AKT pathway"],"prefix":"10.1016","volume":"40","author":[{"given":"Yan","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junpeng","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dianyun","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heshui","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.celrep.2022.111194_bib1","doi-asserted-by":"crossref","first-page":"e27826","DOI":"10.7554\/eLife.27826","article-title":"Identification and dynamics of the human ZDHHC16-ZDHHC6 palmitoylation cascade","volume":"6","author":"Abrami","year":"2017","journal-title":"Elife"},{"key":"10.1016\/j.celrep.2022.111194_bib2","doi-asserted-by":"crossref","first-page":"35195","DOI":"10.1074\/jbc.M503045200","article-title":"Cooperative phosphorylation of the tumor suppressor phosphatase and tensin homologue (PTEN) by casein kinases and glycogen synthase kinase 3beta","volume":"280","author":"Al-Khouri","year":"2005","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.celrep.2022.111194_bib3","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1136\/gutjnl-2013-306627","article-title":"Hepatocellular carcinoma: clinical frontiers and perspectives","volume":"63","author":"Bruix","year":"2014","journal-title":"Gut"},{"key":"10.1016\/j.celrep.2022.111194_bib4","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1126\/science.296.5573.1655","article-title":"The phosphoinositide 3-kinase pathway","volume":"296","author":"Cantley","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.celrep.2022.111194_bib5","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1146\/annurev.pathol.4.110807.092311","article-title":"PTEN and the PI3-kinase pathway in cancer","volume":"4","author":"Chalhoub","year":"2009","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.celrep.2022.111194_bib6","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S1470-2045(08)70285-7","article-title":"Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial","volume":"10","author":"Cheng","year":"2009","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.celrep.2022.111194_bib7","doi-asserted-by":"crossref","DOI":"10.1177\/15347354221078888","article-title":"Combination of ShuangDan capsule and sorafenib inhibits tumor growth and angiogenesis in hepatocellular carcinoma via PI3K\/Akt\/mTORC1 pathway","volume":"21","author":"Ding","year":"2022","journal-title":"Integr. Cancer Ther."},{"key":"10.1016\/j.celrep.2022.111194_bib8","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1053\/j.gastro.2010.09.002","article-title":"Expansion of hepatic tumor progenitor cells in Pten-null mice requires liver injury and is reversed by loss of AKT2","volume":"139","author":"Galicia","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.celrep.2022.111194_bib9","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1038\/s41467-020-15578-1","article-title":"FBXO22 degrades nuclear PTEN to promote tumorigenesis","volume":"11","author":"Ge","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2022.111194_bib10","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/jcp.24689","article-title":"Sorafenib\/regorafenib and lapatinib interact to kill CNS tumor cells","volume":"230","author":"Hamed","year":"2015","journal-title":"J.\u00a0Cell. Physiol."},{"key":"10.1016\/j.celrep.2022.111194_bib11","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1146\/annurev-med-042716-091351","article-title":"PCSK9 inhibitors: mechanisms of action, metabolic effects, and clinical outcomes","volume":"69","author":"Hess","year":"2018","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.celrep.2022.111194_bib12","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1038\/s41388-019-1099-5","article-title":"Targeting the IL-1\u03b2\/EHD1\/TUBB3 axis overcomes resistance to EGFR-TKI in NSCLC","volume":"39","author":"Huang","year":"2020","journal-title":"Oncogene"},{"key":"10.1016\/j.celrep.2022.111194_bib13","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/j.biopha.2018.06.097","article-title":"microRNA-19a-3p promotes tumor metastasis and chemoresistance through the PTEN\/Akt pathway in hepatocellular carcinoma","volume":"105","author":"Jiang","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.celrep.2022.111194_bib14","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.molcel.2018.10.034","article-title":"Phosphorylated RB promotes cancer immunity by inhibiting NF-\u03baB activation and PD-L1 expression","volume":"73","author":"Jin","year":"2019","journal-title":"Mol. Cell"},{"key":"10.1016\/j.celrep.2022.111194_bib15","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1053\/j.gastro.2013.01.053","article-title":"Akt and mTORC1 have different roles during liver tumorigenesis in mice","volume":"144","author":"Kenerson","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.celrep.2022.111194_bib16","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1097\/MOL.0000000000000114","article-title":"PCSK9 and LDLR degradation: regulatory mechanisms in circulation and in cells","volume":"25","author":"Lagace","year":"2014","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.celrep.2022.111194_bib17","doi-asserted-by":"crossref","first-page":"20538","DOI":"10.1073\/pnas.2002964117","article-title":"Mechanism of PRL2 phosphatase-mediated PTEN degradation and tumorigenesis","volume":"117","author":"Li","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celrep.2022.111194_bib18","doi-asserted-by":"crossref","first-page":"e103181","DOI":"10.15252\/embj.2019103181","article-title":"RNA m(6) A methylation regulates sorafenib resistance in liver cancer through FOXO3-mediated autophagy","volume":"39","author":"Lin","year":"2020","journal-title":"EMBO J."},{"key":"10.1016\/j.celrep.2022.111194_bib19","doi-asserted-by":"crossref","first-page":"11851","DOI":"10.1158\/0008-5472.CAN-06-1377","article-title":"Sorafenib blocks the RAF\/MEK\/ERK pathway, inhibits tumor angiogenesis, and induces tumor cell apoptosis in hepatocellular carcinoma model PLC\/PRF\/5","volume":"66","author":"Liu","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.celrep.2022.111194_bib20","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.cellsig.2018.06.011","article-title":"HRD1-mediated PTEN degradation promotes cell proliferation and hepatocellular carcinoma progression","volume":"50","author":"Liu","year":"2018","journal-title":"Cell. Signal."},{"key":"10.1016\/j.celrep.2022.111194_bib21","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/s41586-020-2911-7","article-title":"Inhibition of PCSK9 potentiates immune checkpoint therapy for cancer","volume":"588","author":"Liu","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2022.111194_bib22","doi-asserted-by":"crossref","first-page":"2979","DOI":"10.1016\/j.celrep.2016.11.048","article-title":"Dual Shp2 and Pten deficiencies promote non-alcoholic steatohepatitis and genesis of liver tumor-initiating cells","volume":"17","author":"Luo","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.celrep.2022.111194_bib23","doi-asserted-by":"crossref","first-page":"111758","DOI":"10.1016\/j.biopha.2021.111758","article-title":"PCSK9 and cancer: rethinking the link","volume":"140","author":"Mahboobnia","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.celrep.2022.111194_bib24","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1097\/01.cad.0000173476.67239.3b","article-title":"PI3K\/Akt\/mTOR pathway as a target for cancer therapy","volume":"16","author":"Morgensztern","year":"2005","journal-title":"Anti Cancer Drugs"},{"key":"10.1016\/j.celrep.2022.111194_bib25","doi-asserted-by":"crossref","first-page":"13513","DOI":"10.1073\/pnas.95.23.13513","article-title":"The lipid phosphatase activity of PTEN is critical for its tumor supressor function","volume":"95","author":"Myers","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celrep.2022.111194_bib26","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.neo.2015.03.002","article-title":"Dysregulation of AKT pathway by SMYD2-mediated lysine methylation on PTEN","volume":"17","author":"Nakakido","year":"2015","journal-title":"Neoplasia"},{"key":"10.1016\/j.celrep.2022.111194_bib27","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1093\/bib\/bbaa038","article-title":"GPS-Palm: a deep learning-based graphic presentation system for the prediction of S-palmitoylation sites in proteins","volume":"22","author":"Ning","year":"2021","journal-title":"Brief. Bioinform."},{"key":"10.1016\/j.celrep.2022.111194_bib28","doi-asserted-by":"crossref","first-page":"26562","DOI":"10.1074\/jbc.M605391200","article-title":"PCAF modulates PTEN activity","volume":"281","author":"Okumura","year":"2006","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.celrep.2022.111194_bib29","first-page":"2787","article-title":"PCSK9 regulates apoptosis in human neuroglioma u251 cells via mitochondrial signaling pathways","volume":"8","author":"Piao","year":"2015","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.celrep.2022.111194_bib30","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1093\/protein\/gzn039","article-title":"CSS-Palm 2.0: an updated software for palmitoylation sites prediction","volume":"21","author":"Ren","year":"2008","journal-title":"Protein Eng. Des. Sel."},{"key":"10.1016\/j.celrep.2022.111194_bib31","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3727\/096504012X13477145152995","article-title":"PTEN enhances the sensitivity of human hepatocellular carcinoma cells to sorafenib","volume":"20","author":"Ruan","year":"2012","journal-title":"Oncol. Res."},{"key":"10.1016\/j.celrep.2022.111194_bib32","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1074\/jbc.RA119.010221","article-title":"A transient amphipathic helix in the prodomain of PCSK9 facilitates binding to low-density lipoprotein particles","volume":"295","author":"Sarkar","year":"2020","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.celrep.2022.111194_bib33","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1002\/dneu.22372","article-title":"ZDHHC16 modulates FGF\/ERK dependent proliferation of neural stem\/progenitor cells in the zebrafish telencephalon","volume":"76","author":"Shi","year":"2016","journal-title":"Dev. Neurobiol."},{"key":"10.1016\/j.celrep.2022.111194_bib34","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/nrm3330","article-title":"The functions and regulation of the PTEN tumour suppressor","volume":"13","author":"Song","year":"2012","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.celrep.2022.111194_bib35","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1593\/neo.121252","article-title":"Proprotein convertase subtilisin\/kexin type 9 deficiency reduces melanoma metastasis in liver","volume":"14","author":"Sun","year":"2012","journal-title":"Neoplasia"},{"key":"10.1016\/j.celrep.2022.111194_bib36","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1002\/hep.28574","article-title":"Metallothionein-1G facilitates sorafenib resistance through inhibition of ferroptosis","volume":"64","author":"Sun","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.celrep.2022.111194_bib37","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.cell.2006.11.040","article-title":"Ubiquitination regulates PTEN nuclear import and tumor suppression","volume":"128","author":"Trotman","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2022.111194_bib38","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1089\/ars.2007.1628","article-title":"Detection and characterization of tumor hypoxia using pO2 histography","volume":"9","author":"Vaupel","year":"2007","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.celrep.2022.111194_bib39","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/s41419-017-0120-6","article-title":"Targeting EHMT2 reverses EGFR-TKI resistance in NSCLC by epigenetically regulating the PTEN\/AKT signaling pathway","volume":"9","author":"Wang","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.celrep.2022.111194_bib40","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.cell.2006.11.039","article-title":"NEDD4-1 is a proto-oncogenic ubiquitin ligase for PTEN","volume":"128","author":"Wang","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2022.111194_bib41","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.jhep.2016.04.019","article-title":"ADRB2 signaling promotes HCC progression and sorafenib resistance by inhibiting autophagic degradation of HIF1\u03b1","volume":"65","author":"Wu","year":"2016","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.celrep.2022.111194_bib42","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.numecd.2020.08.012","article-title":"Diallyl disulfide improves lipid metabolism by inhibiting PCSK9 expression and increasing LDL uptake via PI3K\/Akt-SREBP2 pathway in HepG2 cells. Nutrition, metabolism, and cardiovascular diseases","volume":"31","author":"Wu","year":"2021","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"10.1016\/j.celrep.2022.111194_bib43","first-page":"2055","article-title":"Hydrogen sulfide inhibits PCSK9 expression through the PI3K\/Akt-SREBP-2 signaling pathway to influence lipid metabolism in HepG2 cells","volume":"43","author":"Xiao","year":"2019","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.celrep.2022.111194_bib44","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.3892\/etm.2017.4218","article-title":"PCSK9 regulates apoptosis in human lung adenocarcinoma A549 cells via endoplasmic reticulum stress and mitochondrial signaling pathways","volume":"13","author":"Xu","year":"2017","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.celrep.2022.111194_bib45","doi-asserted-by":"crossref","first-page":"152565","DOI":"10.1016\/j.prp.2019.152565","article-title":"Decreased IL-6 induces sensitivity of hepatocellular carcinoma cells to sorafenib","volume":"215","author":"Yang","year":"2019","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.celrep.2022.111194_bib46","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/s41551-019-0375-6","article-title":"Inhibiting PD-L1 palmitoylation enhances T-cell immune responses against tumours","volume":"3","author":"Yao","year":"2019","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.celrep.2022.111194_bib47","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.cmet.2014.01.019","article-title":"Cholesteryl ester accumulation induced by PTEN loss and PI3K\/AKT activation underlies human prostate cancer aggressiveness","volume":"19","author":"Yue","year":"2014","journal-title":"Cell Metab."},{"key":"10.1016\/j.celrep.2022.111194_bib48","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/hep.22354","article-title":"Proprotein convertase subtilisin\/kexin type 9 (PCSK9): hepatocyte-specific low-density lipoprotein receptor degradation and critical role in mouse liver regeneration","volume":"48","author":"Zaid","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.celrep.2022.111194_bib49","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1158\/1535-7163.MCT-13-1043","article-title":"Inhibition of Akt reverses the acquired resistance to sorafenib by switching protective autophagy to autophagic cell death in hepatocellular carcinoma","volume":"13","author":"Zhai","year":"2014","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.celrep.2022.111194_bib50","doi-asserted-by":"crossref","first-page":"e2201","DOI":"10.1038\/cddis.2015.324","article-title":"Galectin-1 induces hepatocellular carcinoma EMT and sorafenib resistance by activating FAK\/PI3K\/AKT signaling","volume":"7","author":"Zhang","year":"2016","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.celrep.2022.111194_bib51","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s40164-021-00218-1","article-title":"PCSK9 promotes tumor growth by inhibiting tumor cell apoptosis in hepatocellular carcinoma","volume":"10","author":"Zhang","year":"2021","journal-title":"Exp. Hematol. Oncol."}],"container-title":["Cell Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211124722010117?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211124722010117?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T11:48:27Z","timestamp":1761911307000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211124722010117"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":51,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["S2211124722010117"],"URL":"https:\/\/doi.org\/10.1016\/j.celrep.2022.111194","relation":{},"ISSN":["2211-1247"],"issn-type":[{"value":"2211-1247","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"S-palmitoylation of PCSK9 induces sorafenib resistance in liver cancer by activating the PI3K\/AKT pathway","name":"articletitle","label":"Article Title"},{"value":"Cell Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.celrep.2022.111194","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s).","name":"copyright","label":"Copyright"}],"article-number":"111194"}}